title: Case of blastic plasmacytoid dendritic cell neoplasm.
authors.forename: Jun
authors.initials: J
authors.lastname: Aoi
authors.forename: Aki
authors.initials: A
authors.lastname: Ogata
authors.forename: Takamitsu
authors.initials: T
authors.lastname: Makino
authors.forename: Keisuke
authors.initials: K
authors.lastname: Sakai
authors.forename: Shinichi
authors.initials: S
authors.lastname: Masuguchi
authors.forename: Satoshi
authors.initials: S
authors.lastname: Fukushima
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Jinnin
authors.forename: Yuji
authors.initials: Y
authors.lastname: Inoue
authors.forename: Hironobu
authors.initials: H
authors.lastname: Ihn
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003713:Dendritic Cells / Q000473:pathology*; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D019337:Hematologic Neoplasms / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D012074:Remission Induction; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*; D033581:Stem Cell Transplantation; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D008727:Methotrexate